STUDY: Hep C Cures Effective For People With HIV/HCV Coinfection
The World Health Organization estimates that globally, 5-15% of people living with HIV are coinfected with hepatitis C. In the United States, about 25% of people living with HIV also have hepatitis C (HCV)—and HCV rates are even higher among people with HIV who inject drugs.
For both hepatitis B and hepatitis C infection, disease progresses faster and causes more liver-related health problems among people with HIV than among those who do not have HIV infection. According to the Centers for Disease Control and Prevention [PDF 328 KB], people who are coinfected with HIV and HCV are nearly three times more likely to develop liver disease, liver failure, and liver-related death from HCV than people with HCV alone.
LIKE BlackDoctor.org on Facebook! Get Your Daily Medicine…For LIFE!
Averting these dangerous health outcomes has been a challenge for people with HIV/HCV coinfection because many previous treatments for HCV were not recommended for people with HIV. These older treatments included interferon and other drugs with side effects that were often severe and included potential adverse interactions with HIV drugs.